Quad Five — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Quad Five is a long-established, privately-held supplier of medical-grade animal blood and serum, serving as a critical raw material provider for the global in vitro diagnostics (IVD) industry. The company operates a vertically integrated, ranch-based production model in Montana, ensuring control over animal health, welfare, and product purity. Its value proposition centers on guaranteed traceability, antibiotic-free sourcing, and customized, on-demand products, which support advanced diagnostic testing for diseases like HIV/AIDS. While not a drug developer, Quad Five is an essential enabler for diagnostic manufacturers and testing laboratories.

Drug Delivery

Technology Platform

A vertically integrated, ranch-based platform for producing medical-grade animal blood and serum. It guarantees 100% traceability, uses only antibiotic-free donor animals, and follows strict protocols for animal welfare and product consistency to supply critical raw materials for diagnostic testing.

Opportunities

The growing and increasingly regulated global IVD market demands high-quality, traceable biological reagents, creating a strong tailwind for Quad Five's niche.

Trends towards supply chain regionalization and ethical sourcing further enhance the appeal of its U.S.-based, sustainable operation.

Offering customized products allows it to address specialized diagnostic needs and build sticky customer relationships.

Risk Factors

Operational risk is concentrated in a single ranch location, making the business vulnerable to disease outbreaks, natural disasters, or other disruptions affecting its animal herds.

It faces competition from larger, diversified biological suppliers and must maintain rigorous compliance with evolving regulatory standards for diagnostic component manufacturing.

Competitive Landscape

Quad Five competes in the niche market for high-quality, traceable animal blood products for diagnostics. It differentiates itself through its 100% donor-animal, antibiotic-free model and guaranteed traceability, which it claims is unique in the U.S. Broader competition comes from large global biological and reagent suppliers (e.g., Thermo Fisher, Merck) and other regional animal blood producers who may not offer the same level of supply chain transparency.

More companies in Biologics / Biosimilars →More companies in United States →